ML400
CAS No. 1908414-42-5
ML400( —— )
Catalog No. M34104 CAS No. 1908414-42-5
ML400 (CID73050863) is an allosteric inhibitor of LMPTP with an EC50 of 1μM. ML400 displays good cell-based activity and rodent pharmacokinetics.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 149 | Get Quote |
|
| 5MG | 181 | Get Quote |
|
| 10MG | 297 | Get Quote |
|
| 25MG | 457 | Get Quote |
|
| 50MG | 632 | Get Quote |
|
| 100MG | 853 | Get Quote |
|
| 500MG | 1701 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameML400
-
NoteResearch use only, not for human use.
-
Brief DescriptionML400 (CID73050863) is an allosteric inhibitor of LMPTP with an EC50 of 1μM. ML400 displays good cell-based activity and rodent pharmacokinetics.
-
DescriptionML 400 is a potent and selective LMPTP inhibitor with an IC50 value of 1680 nM. ML 400 inhibits adipogenesis.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetPhosphatase
-
RecptorPhosphatase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1908414-42-5
-
Formula Weight375.51
-
Molecular FormulaC24H29N3O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESN(CCCN1CCCCC1)C=2C3=C(N=C(C2)C4=CC=C(OC)C=C4)C=CC=C3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Ardecky RJ, et al. Allosteric Small Molecule Inhibitors of LMPTP. 2014 Apr 15 [updated 2015 Jan 16]. In: Probe Reports from the NIH Molecular Libraries Program [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2010–.?
molnova catalog
related products
-
LMPTP INHIBITOR 1 di...
LMPTP INHIBITOR 1 dihydrochloride is a selective inhibitor of low molecular weight protein tyrosine phosphatase (LMPTP), with an?IC50?of 0.8 μM LMPTP-A.
-
SHP099
SHP099 free base is an effective, selective, orally bioavailable, and efficacious SHP2 inhibitor (IC50 =0.07 μM and p-ERK modulation in cells IC50 = 0.250 μM). SHP099 shows dose-dependent pathway inhibition and antitumor activity in xenograft models.
-
Osunprotafib
Osunprotafib (ABBV-CLS-484) is a potent, orally bioavailable PTP1B/PTPN2 inhibitor in clinical trials for solid tumors.
Cart
sales@molnova.com